Skip to main content
. 2014 Mar 23;2014:178132. doi: 10.1155/2014/178132

Figure 2.

Figure 2

Representative case of corneal neovascularization treated with subconjunctival injection of bevacizumab. Patient was a 63-year-old female with chronic keratoconjunctivitis and rheumatoid arthritis. The baseline photograph shows circumferential (360 degrees) neovascularization (NV) of cornea (left). Six months after subconjunctival bevacizumab treatment, NV decreased significantly (right).